<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32895</article-id><article-id pub-id-type="doi">10.26442/00403660.2018.12.000009</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comparative effectiveness of vitamin-mineral complexes with iron in correcting iron deficiency in women in the outpatient setting</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительная эффективность витаминно-минеральных комплексов железа в коррекции железодефицита у женщин в амбулаторных условиях</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Svistunov</surname><given-names>A A</given-names></name><name xml:lang="ru"><surname>Свистунов</surname><given-names>Андрей Алексеевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., член-корр. РАН, первый проректор; ORCID: 0000-0003-1592-5703</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Osadchuk</surname><given-names>M A</given-names></name><name xml:lang="ru"><surname>Осадчук</surname><given-names>Михаил Алексеевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. каф. поликлинической терапии лечебного фак-та; ORCID: 0000-0003-0485-6802</p></bio><email>policlinic_therapy@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kireeva</surname><given-names>N V</given-names></name><name xml:lang="ru"><surname>Киреева</surname><given-names>Наталья Викторовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доц. каф. поликлинической терапии лечебного фак-та; ORCID: 0000-0002-3467-886X</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazareva</surname><given-names>A E</given-names></name><name xml:lang="ru"><surname>Лазарева</surname><given-names>Алиса Евгеньевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент каф. поликлинической терапии лечебного фак-та; ORCID: 0000-0003-3590-5494</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shorina</surname><given-names>D A</given-names></name><name xml:lang="ru"><surname>Шорина</surname><given-names>Дария Андреевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент каф. поликлинической терапии лечебного фак-та; ORCID: 0000-0003-0800-5853</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vasil'eva</surname><given-names>I N</given-names></name><name xml:lang="ru"><surname>Васильева</surname><given-names>Инна Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доц. каф. поликлинической терапии лечебного фак-та</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savina</surname><given-names>T S</given-names></name><name xml:lang="ru"><surname>Савина</surname><given-names>Тамара Сергеевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., ассистент каф. поликлинической терапии лечебного фак-та</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tuaeva</surname><given-names>E M</given-names></name><name xml:lang="ru"><surname>Туаева</surname><given-names>Елена Михайловна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., ассистент каф. поликлинической терапии лечебного фак-та</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of Polyclinic Therapy of the Faculty of Medicine</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>90</volume><issue>12</issue><issue-title xml:lang="en">VOL 90, NO12 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 90, №12 (2018)</issue-title><fpage>56</fpage><lpage>60</lpage><history><date date-type="received" iso-8601-date="2020-04-11"><day>11</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/32895">https://ter-arkhiv.ru/0040-3660/article/view/32895</self-uri><abstract xml:lang="en"><p>Aim. To compare the efficacy of prophylactic administration of mineral-vitamin complexes "Feroglobin-B12" and "Complivit iron" with different degrees of Fe valence. Materials and methods. 120 female subjects were examined. To determine the quality of life, the SF-36 questionnaire was used. The presence of anxiety was determined on the Spielberger-Khanin Alarm Scale. 30 women with a deficit of Fe were divided into 2 groups of 15 people each. The first group received "Ferroglobin-B12", the second - "Complivit iron" for a month. Results. In a month after the initiation of preventive therapy in women of the 1 group the content of Fe serum was normalized. In the second group, its concentration approached the control values. The difference in Fe content in the 1 and 2 groups was of a reliable nature. Conclusion. The intake of "Ferroglobin-B12" was not accompanied by side effects, and performance indicators, social activity and mental health reached control values, unlike the group of patients taking Complivit iron.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Сравнение эффективности профилактического назначения минерально-витаминных комплексов «Фероглобин-В12» и «Компливит железо» с разной степенью валентности железа. Материалы и методы. Обследовано 120 лиц женского пола. Для определения качества жизни пользовались опросником SF-36. Наличие тревоги определяли по Шкале тревоги Спилбергера-Ханина. Тридцать женщин с дефицитом железа разделили на две группы, по 15 человек в каждой. Первая группа получала «Фероглобин-В12», 2-я - «Компливит железо» в течение месяца. Результаты. Через месяц после начала профилактической терапии у женщин 1-й группы достигнута нормализация содержания железа в сыворотке крови. Во 2-й группе его концентрация приближалась к контрольным значениям. При этом разница в содержании железа в 1-й и 2-й группах носила достоверный характер. Заключение. Прием «Фероглобина-В12» не сопровождался побочными эффектами, а показатели работоспособности, социальной активности и психического здоровья достигали контрольных значений, в отличие от группы пациентов, принимающих «Компливит железо».</p></trans-abstract><kwd-group xml:lang="en"><kwd>iron deficiency</kwd><kwd>prophylaxis</kwd><kwd>"Feroglobin-B12"</kwd><kwd>ferric ammonium citrate</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дефицит железа</kwd><kwd>профилактика</kwd><kwd>«Фероглобин-В12»</kwd><kwd>цитрат железа-аммония</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneva, Switzerland: World Health Organization; 2008.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Iron and Health. Scientific Advisory Committee on Nutrition. 2010. London: TSO. P. 3. Published by TSO (The Stationery Office). Available from: https://www.tsoshop.co.uk/</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wilson K, Sloan J.M. Iron-Deficiency Anemia. New Engl J Med (NEJM/MMS). 2015;373(5):484-6. doi: 10.1056/nejmc1507104</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Pereira D.I, Bruggraber S.F, Faria N, Poots L.K, Tagmount M.A, Aslam M.F, Frazer D.M, Vulpe C.D, Anderson G.J, Powell J.J. Nanoparticulate iron (III) oxo - hydroxide delivers safe iron that is well absorbed and utilised in humans. Nanomedicine. 2014;10:1877-86. doi: 10.1016/j.nano.2014.06.012</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>World Health Organization. Global targets indicators: what is measured gets done [online]. Geneva, Switzerland: WHO; 2014. Accessed on April 19, 2018. Available from: http://www.who.int/nutrition/globaltargets_indicators/en/</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>World Health Organization. The global prevalence of anaemia in 2011. Accessed on April 19, 2018. Available from: http://apps.who.int/iris/bitstream/10665/177094/1/9789241564960_eng.pdf</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Roman Viñas B, Ribas Barba L, Ngo J, Gurinovic M, Novakovic R, Cavelaars A, de Groot L.C, van’t Veer P, Matthys C, Serra Majem L. Projected prevalence of inadequate nutrient intakes in Europe. Ann Nutr Metabol. 2011;59(2-4):84-95. doi: 10.1159/000332762</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hurrell R, Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010;91(5):1461S-7S. doi: 10.3945/ajcn.2010.28674f</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Sharp P.A. Intestinal Iron Absorption: Regulation by Dietary &amp; Systemic Factors. Intern J Vitamin Nutrit Res. 2010;80(45):231-42. doi: 10.1024/0300-9831/a000029</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Flour Fortification Innitiative (FFI). Wheat Flour Fortification Status - December 2016. Map of Global Progress. Countries with Mandatory Wheat Flour Fortification Regulations. Online: http://www.ffinetwork.org/global_progress/index.php. Accessed on April 19, 2018.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Pasricha S-R, Low M, Thompson J, Farrell A, De-Regil L-M. Iron Supplementation Benefits Physical Performance in Women of Reproductive Age: A Systematic Review and Meta-Analysis. J Nutrit. 2014;144(6):906-14. doi: 10.3945/jn.113.189589</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Moreiras O, Carvajal A, Cabrera L, Cuadrado C. Tablas de Composición de los Alimentos. Ingestas Recomendadas de Energía y Nutrientes Para la Población Española (Revisadas 2015). Madrid, Spain: Pirámide; 2015. P. 258-9 (In Span.).</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press; 2001. doi: 10.17226/10026</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Harvey-Leeson S, Karakochuk C.D, Hawes M, Tugirimana P.L, Bahizire E, Akilimali P.Z, Michaux K.D, Lynd L.D, Whitfield K.C, Moursi M, Boy E, Foley J, McLean J, Houghton L.A, Gibson R.S, Green T.J. Anemia and Micronutrient Status of Women of Childbearing Age and Children 6-59 Months in the Democratic Republic of the Congo. Nutrients. 2016;8(2):98. doi: 10.3390/nu8020098</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Karakochuk C.D, Whitfield K.C, Barr S.I, Lamers Y, Devlin A.M, Vercauteren S.M, Kroeun H, Talukder A, Mc Lean J, Green T.J. Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia. J Nutrit. 2014;145(1):134-42. doi: 10.3945/jn.114.198945</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Стуклов Н.И., Семенова Е.Н. Железодефицитная анемия. Современная тактика диагностики и лечения, критерии эффективности терапии. Клиническая медицина. 2013;(12):61-7</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lane D.J, Richardson D.R. The active role of vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption! Free Radical Biol Med. 2014;75:69-83. doi: 10.1016/j.freeradbiomed.2014.07.007</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Громова О.А., Торшин И.Ю., Хаджидис А.К. Анализ молекулярных механизмов воздействия железа (II), меди, марганца в патогенезе железодефицитной анемии. Клиническая фармакология и фармаэкономика. 2010;(1):1-9</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Schleicher R.L, Carroll M.D, Ford E.S, Lacher D.A. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutrit. 2009;90(5):1252-63. doi: 10.3945/ajcn.2008.27016</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bird J.K, Murphy R.A, Ciappio E.D, Mc Burney M.I. Risk of Deficiency in Multiple Concurrent Micronutrients in Children and Adults in the United States. Nutrients. 2017;9(7):655. doi: 10.3390/nu9070655</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Ахрем А.А., Андреюк Г.М., Киселева С.И., Кисель М.А., Киселев П.А., Дальнова Т.С., Колб В.Г., Светлицкая С.Г. Определение гемоглобина крови с использованием додецилсульфата натрия. Лабораторное дело. 1989;(5):13-5</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ware J.E.Jr, Sherbourne C.D. The MOS 36-item short - form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473-83. doi: 10.1097/00005650-199206000-00002</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Cancelo-Hidalgo M.J, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, Manasanch J, Perez-Edo L. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin. 2013;29(4):291-303. doi: 10.1185/03007995.2012.761599</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Zhang H, Onning G, Oste R, Gramatkovski E, Hulthén L. Improved iron bioavailability in an oat - based beverage: the combined effect of citric acid addition, dephytinization and iron supplementation. Eur J Nutrit. 2007;46(2):95-102. doi: 10.1007/s00394-006-0637-4</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Fukushima T, Sia A.K, Allred B.E, Nichiporuk R, Zhou Z, Andersen U.N, Raymondet K.N. Bacillus cereus iron uptake protein fishes out an unstable ferric citrate trimer. Proceed Nat Acad Sci. 2012;109(42):16829-34. doi: 10.1073/pnas.1210131109</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Rellán-Alvarez R, Giner-Martínez-Sierra J, Orduna J, Orera I, Rodríguez-Castrillón J.A, García-Alonso J.I, Abadía J, Alvarez-Fernández A. Identification of a tri - iron(III), tri - citrate complex in the xylem sap of iron - deficient tomato resupplied with iron: new insights into plant iron long - distance transport. Plant Cell Physiol. 2009;51(1):91-102. doi: 10.1093/pcp/pcp170</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wang H, Li Z, Niu J, Xu Y, Ma L, Lu A, Wang X, Qian Z, Huang Z, Jin X, Leng Q, Wang J, Zhong J, Sun B, Meng G. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018;4(1):14. doi: 10.1038/s41421-018-0013-6</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Guo X, Zheng H, Guo Y, Wang Y, Anderson G.J, Ci Y, Yu P, Geng L, Chang Y.Z. Nasal delivery of nanoliposome - encapsulated ferric ammonium citrate can increase the iron content of rat brain. J Nanobiotechnol. 2017;15(1):1. doi: 10.1186/s12951-017-0277-2</mixed-citation></ref></ref-list></back></article>
